Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Agios Pharmaceuticals, Inc. (AGIO)

« Back to company index

AGIO Chatter Timeline

Stock Ticker for AGIO

Most Active Tweeters for AGIO

UserTweets
@BlueBioNow 6
@gcassidy718 6
@rmacmillan310 4
@AmericanBanking 4
@stockhoot 3

Recent Tweets for AGIO

InsiderAlerts4U @InsiderAlerts4U
$AGIO: New Insider Filing on AGIOS PHARMACEUTICALS, INC.'s Principal Accounting Officer CARMAN ALENSON: https://t.co/NHNRy0CAof
October 19th 2020, 5:10pm
TargetPrices @TargetPrices
$AGIO latest ratings on 2020-10-19 at Stock Target Advisor https://t.co/ABWniM3prp : Canaccord Genuity (Reiterated… https://t.co/LNBbect7or
October 19th 2020, 4:10pm
Gambiste1 @Gambiste1
RT @MarcJacksonLA: $AGIO Agios' Tibsovo has an FDA green light in AML. Why did European regulators turn it back? https://t.co/fINUjme7Bq
October 19th 2020, 3:10pm
mediasentiment @mediasentiment
$AGIO new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 1471
October 19th 2020, 2:10pm
mediasentiment @mediasentiment
$AGIO new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 1470
October 19th 2020, 2:10pm
AmericanBanking @AmericanBanking
Needham & Company LLC Trims Agios Pharmaceuticals $AGIO Target Price to $69.00 https://t.co/fashm5Q53u #stocks
October 19th 2020, 2:10pm
TranscriptDaily @TranscriptDaily
Needham & Company LLC Cuts Agios Pharmaceuticals $AGIO Price Target to $69.00 https://t.co/jGp2mmMOzH
October 19th 2020, 1:10pm
OlympiaReport @OlympiaReport
Needham & Company LLC Cuts Agios Pharmaceuticals $AGIO Price Target to $69.00 https://t.co/I6ApInMyed
October 19th 2020, 1:10pm
stockhoot @stockhoot
$AGIO Needham Maintains to Buy : PT $69.00 https://t.co/DIt3JvlnIR
October 19th 2020, 12:10pm
MarcJacksonLA @MarcJacksonLA
$AGIO Agios' Tibsovo has an FDA green light in AML. Why did European regulators turn it back? https://t.co/fINUjme7Bq
October 19th 2020, 12:10pm
HealthcareBeat @HealthcareBeat
Agios: A Look At TIBSOVO In CC Patients $AGIO https://t.co/TrSVKSQFrA
October 19th 2020, 11:10am
stockhoot @stockhoot
$AGIO SVB Leerink Maintains to Outperform : PT $67.00 https://t.co/aX01VWt55m
October 19th 2020, 11:10am
AmericanBanking @AmericanBanking
SVB Leerink Lowers Agios Pharmaceuticals $AGIO Price Target to $67.00 https://t.co/k6eCZzO17I #stocks
October 19th 2020, 11:10am
SeekingAlpha @SeekingAlpha
$AGIO - Agios: A Look At TIBSOVO In CC Patients. https://t.co/XlCXHgurJs #business #markets #trading
October 19th 2020, 10:10am
stocknewstimes @stocknewstimes
Agios Pharmaceuticals $AGIO PT Lowered to $67.00 at SVB Leerink https://t.co/aTzoZmtMM8
October 19th 2020, 10:10am
AmericanBanking @AmericanBanking
Agios Pharmaceuticals $AGIO PT Lowered to $73.00 at Piper Sandler https://t.co/QeJamtAFJ3 #stocks
October 19th 2020, 9:10am
AmericanBanking @AmericanBanking
Agios Pharmaceuticals $AGIO Given Buy Rating at Canaccord Genuity https://t.co/CnkLvDtV1d #stocks
October 19th 2020, 9:10am
HammerstoneMar3 @HammerstoneMar3
$AGIO -2.7% as withdrew its European Marketing Authorization Application for Tibsovo to treat certain adult patient… https://t.co/iHQczxlyYw
October 19th 2020, 9:10am
TargetPrices @TargetPrices
$AGIO Reiterated by Canaccord Genuity Buy USD 70 Maintains Piper Sandler Overweight USD 80 » USD 73 https://t.co/jWZKPRbGoQ
October 19th 2020, 8:10am
ZolmaxNews @ZolmaxNews
Canaccord Genuity Reaffirms Buy Rating for Agios Pharmaceuticals $AGIO https://t.co/ok5pKs1lLW
October 19th 2020, 8:10am
stockhoot @stockhoot
$AGIO Piper Sandler Maintains to Overweight : PT $73.00 https://t.co/rbu1z0bMbg
October 19th 2020, 7:10am
dispatchtribune @dispatchtribune
Canaccord Genuity Reaffirms Buy Rating for Agios Pharmaceuticals $AGIO https://t.co/gOAbYaPJtc
October 19th 2020, 7:10am
sbwcws @sbwcws
Agios withdraws European Marketing Authorization application for Tibsovo $AGIO
October 19th 2020, 4:10am
AdamBilko @AdamBilko
RT @d_pavlos: $AGIO Daily chart Potential wave 4 target 42-45 Entry 37.30 Stop 34.70 https://t.co/i76z9jX5mL
October 18th 2020, 2:10pm
WeekHerald @WeekHerald
Agios Pharmaceuticals Inc $AGIO Given Consensus Recommendation of “Buy” by Analysts https://t.co/UOJ0PC79YY
October 18th 2020, 1:10pm
d_pavlos @d_pavlos
$AGIO Daily chart Potential wave 4 target 42-45 Entry 37.30 Stop 34.70 https://t.co/i76z9jX5mL
October 18th 2020, 10:10am
MarketChmln @MarketChmln
$AGIO option volume was 14X normal on Friday with 2,643 contracts. Call volume was 81% and put volume was 19%. https://t.co/UlJfA2ku33
October 17th 2020, 6:10pm
HealthcareBeat @HealthcareBeat
Agios falls after pulling European marketing application for Tibsovo $AGIO https://t.co/iBX7pYGYL8
October 17th 2020, 12:10am
tq_equities @tq_equities
$AGIO closes within prior day's range: https://t.co/twcMYFJLWF Sentiment: Neutral #AGIO #Agios
October 16th 2020, 8:10pm
colabinno @colabinno
RT @JohnCendpts: PhI data from $AGIO is getting more scrutiny? European regulators spurn Agios' AML drug Tibsovo, unconvinced by the same t…
October 16th 2020, 7:10pm
Briefingcom @Briefingcom
$AGIO: Agios Pharma withdraws European MAA for TIBSOVO as treatment for relapsed or refractory IDH1-mutant AML https://t.co/b2VMxsRg03
October 16th 2020, 6:10pm
JohnCendpts @JohnCendpts
PhI data from $AGIO is getting more scrutiny? European regulators spurn Agios' AML drug Tibsovo, unconvinced by the… https://t.co/GvCgyMQVFF
October 16th 2020, 4:10pm
YuZhu4 @YuZhu4
RT @BioStocks: $AGIO Announces Withdrawal of European Marketing Authorization Application for TIBSOVO as a Treatment for Relapsed or Refrac…
October 16th 2020, 4:10pm
MaisaCorp @MaisaCorp
$AGIO has withdrawn its application to market Tibsovo to treat relapsed or refractory acute myeloid leukemia in Eur… https://t.co/aSP4DKG7oj
October 16th 2020, 4:10pm
MarketCurrents @MarketCurrents
$AGIO - Agios falls after pulling European marketing application for Tibsovo https://t.co/le9jIuT32S
October 16th 2020, 4:10pm
otcdynamics @otcdynamics
$AGIO Agios Announces Withdrawal of European Marketing Authorization Application for TIBSOVO® as a Treatment for Re… https://t.co/EunyAqJa2Q
October 16th 2020, 4:10pm
MarcJacksonLA @MarcJacksonLA
$AGIO Agios Announces Withdrawal of European Marketing Authorization Application for TIBSOVO® as a Treatment for Re… https://t.co/Wk5AJvCCXR
October 16th 2020, 4:10pm
dsobek @dsobek
RT @zbiotech: $AGIO Agios Announces Withdrawal of European Marketing Authorization Application for TIBSOVO® as a Treatment for Relapsed or…
October 16th 2020, 4:10pm
FlashAlert_me @FlashAlert_me
$AGIO [15s. delayed]: Issued Press Release on October 16, 16:01:00: Agios Announces Withdrawal of European Marketin… https://t.co/gpG2Q3k9ko
October 16th 2020, 4:10pm
BioStocks @BioStocks
$AGIO Announces Withdrawal of European Marketing Authorization Application for TIBSOVO as a Treatment for Relapsed… https://t.co/iqnjXN0Pdl
October 16th 2020, 4:10pm
zbiotech @zbiotech
$AGIO Agios Announces Withdrawal of European Marketing Authorization Application for TIBSOVO® as a Treatment for R… https://t.co/ULlilF7mGD
October 16th 2020, 4:10pm
stock_titan @stock_titan
$AGIO Agios Announces Withdrawal of European Marketing Authorization Application for TIBSOVO® as a Treatment for Re… https://t.co/zUiBX4RoFn
October 16th 2020, 4:10pm
BlueBioNow @BlueBioNow
$AGIO buyer at $38.69 -3.38 % change recently https://t.co/cCpkeLIzDz
October 16th 2020, 3:10pm
portefeuillefun @portefeuillefun
Sold 1k $AGIO at $36.34, now 5k #vssporte shares.
October 16th 2020, 10:10am
gcassidy718 @gcassidy718
$AGIO Would say I'm surprised, but I'm not. Will check ER. Might dabble again. Maybe. -3.38 % change recently https://t.co/mS39GkmyEi
October 16th 2020, 9:10am
BlueBioNow @BlueBioNow
$AGIO My valuations is at $40.04. Waiting for it to come down. https://t.co/cCpkeLIzDz
October 15th 2020, 2:10pm
rmacmillan310 @rmacmillan310
$AGIO might be worth taking a position when this bottoms 3.47 % change recently https://t.co/drCD5NUgqy
October 15th 2020, 9:10am
gcassidy718 @gcassidy718
$AGIO substantial stock price changes 3.53 % change recently https://t.co/mS39GkmyEi
October 15th 2020, 3:10am
mikepsilva @mikepsilva
$AGIO Positive divergence, nice volume activity, moving averages showing a trigger entry. Resistance up ahead. Buy… https://t.co/nelMQbGWAM
October 14th 2020, 4:10pm
bigpharmaguy @bigpharmaguy
Seems like $AGIO has nearly zero SCD value built in at the moment relative to $FMTX. NIH presenting at ASH should r… https://t.co/DLgL8jfwi8
October 14th 2020, 12:10pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.